fbpx

Month: April 2020

The value of packaging design goes beyond pretty pictures

The value of packaging design goes beyond pretty pictures says Fred Roeder

When people talk about the importance of design, people will often point to iconic logos and branding that we now take for granted, whether it’s the Coca Cola motif, Mr Pringles crisps or Jack Daniels bottles.

But the importance of design isn’t just in the design itself, but in the intellectual property behind the design and its intrinsic value to brand holders and consumers. Design cues provide information and knowledge around the products consumers buy and help to build confidence. Removing design elements simply limits an individual’s ability to make informed decisions about what they are buying.

Late last year, the outgoing UK Chief Medical Officer, Dame Sally Davies, called on the government to threaten the food industry with ‘cigarette style’ plain packaging for sweets and chocolates if they failed to meet sugar reduction targets. Dame Sally called the for the sugar tax programme – already in place for soft drinks – to be extended to cereals, yogurts and cakes if targets are not met by 2021, and applied to calorie-rich foods by 2024.

Creative solutions

Dame Sally’s parting shot at the food, drink and retailing industry comes hot on the heels of the UK’s Food Ethics Council which also called for an outright ban on cartoon mascots on junk food, including fizzy drinks, crisps, cereals and biscuits, in a bid to curb obesity and diseases like diabetes

No one is denying that a there’s a sensible debate to be had around responsible consumption, but unproven laws are not the solution. Rather than scaring people into changing their behaviour or punishing their pockets through ‘sin taxes’ and brand censorship, legislators need to be more creative when it comes to promoting good health.

While it’s not yet government policy in the UK, it soon could be and it will be interesting to see if Chris Whitty, Dame Sally’s replacement, picks up the cudgel and continues to beat food and drink manufacturers, retailers and consumers into submission.

Lawmakers often take their lead from public health bodies like the Food Ethics Council and supranational organisations 13like the World Health Organisation, who just love to wield the ban hammer in the name of protecting public health.

It’s happening already with Ireland’s Public Health (Alcohol) Bill, which became law in October 2018, regulating advertising and promotion, insisting on mandatory cancer warnings, and banning alcohol branding from sports stadiums.

Restricting marketing and communications in certain product categories and, in some cases, banning their availability altogether, will only serve to stifle innovation and violate consumer rights.

You only have to go back 100 years to the US bringing in the Volstead Act, which prohibited the manufacture and sale of alcoholic beverages, to know that banning something simply drives demand underground, fuelling criminality.

Freedom of choice

Unbranded goods provide a boon for organised crime gangs as the labels, packaging and containers are much easier to fake. Spurred on by the promise of enormous profits, the trade in unregulated illegal products represents a tempting proposition for counterfeiters, with huge costs to governments and the public alike. Therefore, the total damage to businesses affected is likely to be higher. Brand censorship will almost certainly lead to losses in the creative industries, including design and advertising services, which are heavily reliant on FMCG contracts.

Brand Finance estimates that the potential value loss to businesses worldwide would be $430.8bn if tobacco-style plain packaging were extended to the beverage industry. This refers to the loss of value derived specifically from brands and does not account for further potential losses resulting from changes in price and volume of the products sold, or illegal trade.

Compounding the issue is a complete lack of analysis-based dialogue between brand owners, consumers and regulators. IP laws and frameworks are positive examples of these groups working together to protect and enforce the interests of rights holders, whilst at the same time allowing consumers the freedom to make their own choices. Despite these efforts, the infringement of IP rights remains a significant problem. According to a 2019 OECD – EUIPO report, the total volume of trade in fakes was estimated at $509bn, or 3.3 per cent of global trade (up from 2.5 per cent in 2013).

The way forward

No brand has a God-given right to exist or survive. But the threat of restrictive business regulation and illegal trade will only serve to hasten their demise by undermining intellectual property rights and weakening their inherent value.

The Food Ethics Council and Public Health England are right to call for a debate on how we can make the country healthier, but the negative impact of limiting brands could wreak havoc in the packaging and creative industries, causing a major headache for big retailers, with no conclusive evidence that the policy will achieve the desired health objectives.

That is why closer collaboration and co-operation between policymakers and industry participants, and education over legislation, provides the best way forward. Instead of health warnings and brand censorship, we should use incentives and encouragement to change consumer behaviour.

Fred Roeder is the Managing Director of the Consumer Choice Center, an independent non-profit organisation, which promotes ‘consumer choice’ among different products, innovations and price classes. The Consumer Choice Center supports lifestyle freedom, innovation, privacy, science and consumer choice. The CCC believes regulators on local, national and supranational levels keep regulating more and more areas of consumers’ lives. This leads to less consumer choice and makes products more expensive.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Lockdowns have overreached and are flattening our livelihoods

Millions of Americans are in the penalty box as we speak. They have followed the advice of state and local officials and stayed home to stop the spread of COVID-19.

Businesses are on hold, birthdays are canceled, travel is limited, and we are glued to our screens to see how this all ends. While some of us have been able to carry on work, essential or not, during this trying time, that’s just not possible for most.

More than 16 million Americans have filed for unemployment benefits since lockdown orders went into effect in mid-March, and economists say we could face as high as 20% unemployment by summer.

It is certainly true that many states and cities have saved lives by ordering us to stay home. But blanket lockdowns are now flattening our livelihoods in a way that’s more dangerous than this pandemic.

Danish political scientist Bjorn Lomborg says that by closing down all schools and jobs, we are “actually creating more damage, more long term death, more long term unemployment and unpleasantness for the whole population compared to what you’re achieving in saving lives.”

He’s right. It’s why Austria and Denmark have already begun to relax their lockdowns and open up their economies, though with social distancing rules still in effect. European leaders see the real damage that has been done to societies, and it is time to turn the tide while remaining responsible.

That is exactly what the American people can do as well.

We can still be responsible by socially distancing where necessary, wearing facemasks, quarantining at-risk groups and using technology to track the spread of the virus. That is what countries going back to work have done since the start. That will be more effective than forcing businesses to shutter, driving many of our compatriots to food banks or the brink of homelessness.

We have to look no further than our own hospitals.

It’s true that many health facilities in major cities are overwhelmed, and we should be sending them every resource where possible.

But by canceling elective surgeries and operations that feed their budgets, rural and county hospitals have ironically begun laying off hundreds of thousands of health professionals and administrative staff. This is not because they are overwhelmed with COVID-19 patients but rather because they don’t have any patients at all.

If we are losing health professionals during a pandemic, then we’re doing something wrong.

A one-sized fits-all-approach is usually misguided in our federal system, and it’s wrong now. There are 27 states that have had less than 100 fatalities, yet are still imposing crushing lockdowns. It’s no wonder so many are itching to get back to work.

It’s time to admit lockdowns are not a universal answer to the crisis we face.

Many criticize President Trump for his desire to open up the American economy. But his anxiety is a signal to workers and entrepreneurs everywhere: The pain and suffering of the novel coronavirus are real, but losing your income and prospects for feeding your family is just as bad or sometimes even worse.

Americans are a robust, strong and resilient people. We understand that things may never be the same, but we should be trusted to continue our lives while following the guidance of our scientists and doctors.

That is the balance we need to protect our livelihoods and save those most vulnerable.

Yaël Ossowski is deputy director of the Consumer Choice Center. He wrote this for InsideSources.com.

Republished in the Waco Tribune-Herald.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

6 Amazing Medical Breakthroughs we should be thankful for

Thanks to continuous innovation in medical sciences and biotechnology we have seen amazing breakthroughs in medical technology and pharmaceuticals in the past two decades. These breakthroughs would not have been possible without incentives for inventors and investors. We can still only cure or treat 5% of all known diseases. Reducing incentives for innovation and intellectual property rights would risk finding cures for the remaining 95%.

This is a list of just six innovations of the last two decades that dramatically improve the lives of millions of people.

MEP Isabel Benjumea on COVID-19

The terrible COVID-19 pandemic that we are experiencing brings with it not only a health and humanitarian disaster but also an economic, social and political crisis. Faced with this issue, we must not forget that moments of weakness and crisis lay a ground for interventionists and statists of all political affiliations, who will try to take advantage’ of these moments of tremendous uncertainty to push forward their dogmas in societies filled with fear.  

The confinement of citizens as the main measure of prevention against the virus and the extensive powers channelled by governments for that matter can be interpreted as the ideal safeguard to enforce statist dogmas. One of them goes as follows, “only the state is capable of protecting you from this threat [coronavirus] only the  State has a clear understanding of what is happening and acting to that end (thus monopolising information and the truth), it is the State that marks the times and that administers your daily life… Ergo: it is the State that will save you in the end”.

Yet, as is usually the case, reality prevails over utopia and facts take over dogmatic dreams. Let’s look at what’s happening in Spain- my home country – which is also, unfortunately, one of the countries most affected by this terrible pandemic.

In the face of the centralised and interventionist measures of a socialist government that is not very freedom-loving, the private initiative has managed to tackle the exasperating slowness of government management. While the central government was piling up sanitary material to ensure a fair and equal distribution, different companies came together to buy sanitary materials and bring them to our country. While this government got lost in bureaucratic procedures and press conferences without journalists, the public-private collaboration in regions and cities allowed the acquisition of material, the direct management of the public health emergency and even the construction or adaptation of new hospitals. While the socialist government is selling supposed aid to increase public spending, small, medium and large companies, along with individual donors who are giving out thousands of grants and contributions to fight the virus and help the most vulnerable and affected groups.

If we allow the usual statist propaganda to manipulate reality and make up for what is happening, the post-coronavirus era might signify a dangerous return to a dark past. All solutions to this crisis and all contributions to building the future must as always, come from effective and accountable institutions with limited power. And they should embrace a strong private initiative and embrace its role in the global search for the most sensible solution.

And let’s also be clear that those who have seized all the power will not want to give it up easily. An uncontrollable government that has had the opportunity to manage the daily lives of its citizens will not give away that power. That is why we must take it all seriously and insist that each and every one of the individual rights given up in this crisis is preserved.

It is essential to understand these potential dangers before choosing an action plan. Before passing legislation in the fields of health, tax, labour or social affairs, we must be clear about the dangers that lie ahead and the path to follow.

More specifically, in relation to the supply of medicines and health material, I previously used the Spanish case as an example: so far it has been a public-private collaboration that helped find a way out of the gridlock that the country found itself in. And there must be rules and regulations, of course, following the simple maxim: “few and clear”.

Hyper-regulation and bureaucracy that blocks the supply channels makes the products more expensive and delays their delivery and subsequent distribution. Let’s speed up purchases by limiting the security checks instead. The liberalization of the pharmaceutical sector, allowing the sale of medicines that do not need a prescription outside pharmacies and online. It is also crucial to lower the burden faced by the pharmaceutical sector both in its internal organization and in the creation of new enterprises. This may help reduce the price of products.

Alongside this liberalisation, the institutions must focus their regulations on ensuring product quality, especially in such important areas as health. Obviously, the existence of patents that have to overcome all the demanding safety and quality filters is absolutely justifiable. At the same time, they ensure the interest of private research, necessary for public and health benefit. But it will also be the role of the institutions to facilitate the management of patents, to prevent monopolies and abuses in the market that could prevent free competition and its consequent lowering of the price of the product. 

Liberalising measures combined with the security framework to be provided by the institutions, reduction and simplification of the hyper-regulation that delays the management of solutions and public-private collaboration in the search for solutions are the way forward. And the key is that these are not ideological dogmas; they are lessons drawn from observing what is happening; from examining the disastrous reality.


Las opiniones y opiniones expresadas aquí son de los autores y no reflejan necesariamente la política oficial o la posición del Centro de Elección del Consumidor. Cualquier contenido proporcionado por nuestros bloggers o autores es de su opinión.


Consumer Choice Center es el grupo de defensa del consumidor que apoya la libertad de estilo de vida, la innovación, la privacidad, la ciencia y la elección del consumidor. Las principales áreas de política en las que nos enfocamos son digital, movilidad, estilo de vida y bienes de consumo, y salud y ciencia.

El CCC representa a los consumidores en más de 100 países de todo el mundo. Monitoreamos de cerca las tendencias regulatorias en Ottawa, Washington, Bruselas, Ginebra y otros puntos críticos de regulación e informamos y activamos a los consumidores para luchar por #ConsumerChoice. Obtenga más información en consumerchoicecenter.org

疫情之下:各国寻找城市“解围”之路

解除疫情封锁措施涉及两大问题:如何分阶段、渐进地重开部分工作、教育、文化和娱乐场所;需要何种“检测和追踪”机制来发现和遏制新的疫情。

在英国和欧洲大部分地区享受复活节的灿烂阳光之际,几乎无人能参加传统的庆祝活动。为了减少新型冠状病毒肺炎(COVID-19,即2019冠状病毒病)的传播,多数国家已禁止旅行和社交聚会,很多人迫切期待解除封锁,这些封锁措施不仅限制个人生活,还破坏企业和全球经济。

包括奥地利、丹麦和挪威在内的一些欧洲国家宣布,已制定初步计划,将在本月晚些时候放松最严格的封锁措施,例如允许一些商店恢复营业和学校复课。但受疫情影响最严重的国家(意大利、西班牙、法国和英国)的政府不愿公开谈论封锁退出策略。它们不希望在死亡数字仍在上升之际分散人们对遵守封锁措施的关注。

正如英国财政大臣里希•苏纳克(Rishi Sunak)上周所宣称的那样:“目前的首要任务是阻止新冠病毒的传播,到达疫情高峰的另一边。”

但在幕后,全球各国的部长级官员和卫生官员都已开始讨论接下来的事情。围绕退出策略的辩论关注两个主题:如何分阶段、渐进地重新开放部分工作、教育、文化和娱乐场所;一旦最初的疫情浪潮消退,需要何种“检测和追踪”机制来发现和遏制新的疫情。

在欧洲,有迹象表明,绝大多数公众遵守严格的社交疏离措施(遵守度超过很多专家的预期),这导致疫情传播大幅下滑。

关键数据是“传染数”R,它衡量受感染个体传染的新病例的平均数量。如果R大于1,表明疫情会扩散;如果小于1,表明疫情会减弱。对于新冠疫情而言,如果不采取任何措施,多数地区的R在2.5到3之间。

英国抗击新冠疫情的一位权威科学家表示,最新证据显示,现在R大幅降至0.6左右,这将迅速抑制疫情。

然而,由于从感染到出现严重症状之间有时滞,死亡人数仍在迅速增长。

英国首席科学顾问帕特里克•瓦兰斯(Patrick Vallance)上周四表示,有明显迹象表明,新增确诊病例数量正趋于平稳。但他补充称:“我预测未来两周,死亡人数将继续增长。”

苏纳克和他手下的官员不得不快速拿出创新举措,将封锁造成的痛苦降至最低。但他们也明白,封锁持续的时间越长,破产的公司就越多。因此,大臣们正努力思考如何以及何时解除限制,即使是在尚未建立完善的检测和追踪机制的情况下。

一位大臣表示,重点是基于“人口、行业和地域”的3个潜在退出通道。一种选择可能是让年轻人先解禁,可能从学校复课开始,然后是让年轻人复工,这些人被感染后不太可能发展为重症。

一些人被华威大学(Warwick university)安德鲁•奥斯瓦尔德(Andrew Oswald)和纳塔武•鲍德塔威(Nattavudh Powdthavee)的一篇论文所吸引,这篇论文建议取消对20岁到30岁、不和父母一起住的人的限制,这可能会解放420万人。一位官员开玩笑说,“青年优先”政策可能意味着“你甚至会规定在酒吧喝酒的最高年龄”。

英国商务大臣阿洛克•夏尔马(Alok Sharma)上周提出了更为宽容的社交疏离规则指引,暗示了哪些行业可能成为经济复苏的先锋。他要求建筑、制造、物流、基本零售、废物管理和户外行业实施政府的建议,保持2米距离,不过这些行业也得到了如果做不到时如何继续复工的建议。

大臣们对英国分地区重新开放的想法不怎么感兴趣。大曼彻斯特市市长安迪•伯纳姆(Andy Burnham)表示,封锁只有在“全国统一”的情况下才能奏效。在接受BBC《新闻之夜》(Newsnight)采访时他补充道:“如果英国其他地方出现人们回到酒吧的景象,那这里就不可能持续封锁下去。”

尽管代表英国经济利益的大臣们强调首要任务是拯救生命,但他们开始就新冠病毒造成的更广泛损害展开讨论。

英国财相一直在提问,长时间封锁和深度衰退会对公众长期健康产生什么影响,尤其是对较贫困群体的心理健康和福祉的影响。伦敦财政研究所(Institute for Fiscal Studies)上周的一份报告加强了他的疑问。

上周在内阁会议上提出的这一观点的潜台词是:可以呼吁解除封锁,而不只是依靠冷冰冰的经济论据。一位政府官员表示:“你必须全面考虑健康方面的情况。”

等到最初的病例激增期过去,英国及其他各国在最终放松封锁的同时,将会有一个密集“检测和追踪”机制,以发现并消灭病毒的新爆发。许多国家的政府正在仔细研究韩国的经验,韩国建立了一个广泛的检测系统来监测新的感染病例。

如果英国能够在4月底前实现每天进行10万次检测的目标,并在未来几个月进一步提高检测能力,则有可能对社区中报告有新冠肺炎症状的人员进行检测。理论上,如果他们确诊的话,这一步之后是跟踪、检测和隔离与他们有过接触史的人。

这种接触者追踪还涉及直接询问病人,在英国报告出现第一批病例时就开始了,但很快就停止了,因为英国极其有限的检测能力已无法应对这次大流行。

伦敦帝国理工学院(Imperial College London)传染病动力学教授史蒂文•赖利(Steven Riley)表示:“有证据显示,那些能够进行极高水平检测的国家有更多选择,可以允许人们有更大社会流动性。一些真正创新的解决方案将发挥作用。基于一项手机应用的接触者追踪正受到考虑。”

然而,在公民遇到新冠病毒检测呈阳性的人后,能够追踪并通知他们的应用程序对西方民主国家造成了巨大的现实和政策挑战——从确保开放的操作标准到维护数据安全。

例如,在中国,这些健康应用程序在大多数地方并不是强制的,但如果人们无法在一款病毒追踪应用上显示自己的状态,就可能被禁止工作、禁止乘坐公共交通工具、甚至无法去公园。这种病毒追踪应用能够显示人们过去两周的行踪。

隐私保护倡导者的目标是发现潜在的隐私侵犯。Consumer Choice Center驻布鲁塞尔分析师比尔•沃茨(Bill Wirtz)说:“如果追踪个人行踪被提上日程,那么即使在危机时期,也不太可能符合现有隐私法。”

许多科学家认为,结束封锁的关键在于大规模进行能够发现新冠病毒感染的检测。诺贝尔奖得主、经济学家保罗•罗默(Paul Romer)概述了一项在美国进行大规模检测的计划,他认为,这项计划将使美国经济的大部分领域得以重新开放。

然而,这要求每人每14天检测一次,即全国每天检测2200万次。这对实验室、化学制剂、卫生工作人员和数据分析师而言是一项艰巨的任务,即使这些测试在宪法上是可以接受的。在英国,流行病学家朱利安•皮托(Julian Peto)也提出了类似的建议——每人每周检测一次,全国每天检测1000万次。

大规模抗体检测——可以显示出人们此前是否感染过新冠病毒,以及是否仍有一定免疫力——的前景更为诱人,因为这种测试只需要偶尔进行,而且有可能在药店买到。

但首先,它们必须确实可行。专业实验室正在进行研究,以确定人群样本中的抗体水平,但还没有人开发出一种足以在家里广泛使用的可靠抗体试剂盒。经英国政府评估的试剂盒的失败率为30%至50%。

最终,抗体检测可以为人们提供“免疫护照”,证明他们不会被感染,赖利教授表示,“但首先要做一些非常重要的科学研究”。仍然需要回答的关键问题是,不同的抗体水平与对感染的抵抗力有何关系,以及任何免疫保护可能持续多久。

摆脱新冠危机的长期途径需要安全有效的治疗方法和疫苗。目前有数十种药物正在进行临床试验,以确定它们是否对新冠患者有所帮助。一些药物可能会展现出疗效,但如果有任何一种被证明是神药,连药物学家都会感到震惊。即使拥有巨大的资源和监管方面的配合意愿,开发新药和疫苗也需要一年多的时间。

同时,各国政府仍然不知道新冠病毒可能如何出现第二波爆发,也不真正了解人群中能建立多少免疫。

正如帝国理工学院流行病学家、英国政府顾问尼尔•弗格森(Neil Ferguson)教授上周五告诉英国广播公司广播四台(BBC Radio 4)的那样,研究出一项退出策略“是科学界和政府在清醒的每一分钟里考虑的首要话题和重中之重。”

译者/何黎

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Gewollt oder nicht, Julia Klöckner treibt die Gen-Revolution positiv an

Die Bundeslandwirtschaftsministerin hat den richtigen Riecher und steht beim Thema Genschere auf der Seite der Wissenschaft. Zu Recht.

Im Jahr 2012 haben Prof. Dr. Thorsten Stafforst und sein Team an der Universität Tübingen entdeckt, dass man durch die Verknüpfung von Enzymen mit manipulierten RNA-Strängen Gene verändern kann. Neben Ribonukleinsäure (RNA) kommen mittlerweile auch andere Methoden im Bereich Gen-Editing zur Anwendungen, am bekanntesten ist wahrscheinlich die Genschere  CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). Für die Einen bloße Zungenbrecher, für Andere ein lebenswichtiger Durchbruch in Medizin und Landwirtschaft.

Aus medizinischer Sicht ist Gen-Editing vielversprechend im Kampf gegen Krebskrankheiten. Zum Beispiel haben Wissenschaftler in den USA zwei innovative Ansätze miteinander vermischt: CRISPR, bei dem DNA umgeschrieben wird, sowie die T-Zelltherapie, bei der dendritische Zellen (die sogenannten “Wächterzellen”) des Immunsystems zur Zerstörung von Tumoren eingesetzt werden. Drei Patienten erhielten im vergangenen Jahr CRISPR-veränderte Versionen ihrer eigenen Zellen. Geheilt werden konnten die Patienten leider nicht mehr, doch die Recherche ist Gold wert. Es zeigte sich vor allem, dass CRISPR sicher als Behandlung eingesetzt werden kann. Im Jahr 2017 konnten zwei Kleinkinder (11 und 18 Monate alt) in den Vereinigten Staaten mit moderner Zelltherapie erfolgreich behandelt werden.

Ähnlich vielversprechend ist Gen-Editing in der Landwirtschaft. An der Universität Wageningen in den Niederlanden haben Forscher letztes Jahr glutenfreien Weizen herstellen können, indem sie mit CRISPR die für Gluten verantwortlichen Gene entfernten. Für Millionen Europäer, die an Zöliakie leidet, ist dies eine vielversprechende Nachricht.

In Belgien wurden unterdessen Fungus-resistente Bananen geschaffen, doch nach einer Entscheidung der EU-Gerichtshofes in Luxemburg (EUGH) verlor das Projekt seine Finanzierung. Der EUGH hatte 2018 beschlossen, dass Gen-Editing unter die Definition von Genetisch Veränderten Organismen (GVO) fällt und daher durch die GVO-Direktive aus dem Jahr 2001 de facto verboten ist. Diese Entscheidung wurde seitdem konsequent kritisiert. Studenten der Universität Wageningen haben derweilen eine EU-Bürgerinitiative gegründet um die Gesetzgebung zu ändern, doch bei solch wissenschaftlichen Themen und wenig Medieninteresse werden wahrscheinlich am Ende die nötigen Unterschriften fehlen und das Quorum nicht erreicht.

Aus dem deutschsprachigen Raum kommen positive Änderungsvorschläge und Beiträge. Die EU-Bürgerinitiative selbst wurde unter anderem von einer Österreicherin und einer Deutschen gestartet.

Bei der Europäischen Behörde für Lebensmittelsicherheit (EFSA) ist es der Österreicher Dr. Bernhard Url, der darauf verweist, dass es in der Wissenschaft den Unterschied zwischen “Gefahr” und “Risiko” gibt : Die “Gefahr” beschreibt das Potenzial, dass etwas Negatives passieren kann, während “Risiko” quantifiziert wie wahrscheinlich es ist, dass etwas Negatives passiert. So ist beispielsweise Wasser an sich harmlos, doch wer zu viel davon trinkt, kann unter negatives Folgen leiden. Sonnenstrahlen sind ebenso harmlos, doch wer sich nicht richtig davor schützt, also in ungesundem Maße konsumiert, der kann sich verbrennen. Die Aussage, dass die Sonne an sich krebserregend sei, wäre aber bizarr.

Dies ist in der Diskussion rund um die Lebensmittelsicherheit wichtig, da das sogenannte Vorsorgeprinzip in der Europäischen Union herrscht. Gegner des Gen-Editings behaupten, dass dieses Prinzip greifen muss, da es eine Gefahr gibt, also das Potenzial, dass etwas Negatives eintrifft. In Wahrheit geht es darum in der Praxis herauszufinden wie wahrscheinlich es ist, dass es eintrifft, und dann im Einzelfall entscheiden. Würde man das Vorsorgeprinzip zum Beispiel konsequent bei Wasser und Sonne anwenden, müssten diese beiden lebenswichtigen Baustoffe verboten werden.

Bundeslandwirtschaftsministerin Julia Klöckner ist offen gegenüber Gen-Editing in der Landwirtschaft. „Die klassische grüne Gentechnik mit CRISPR/Cas in einen Topf zu werfen, halte ich für sachlich falsch”, sagte Klöckner der Nachrichtenagentur Reuters. Bei der Grünen Woche in Berlin gibt es warme Worte für CRISPR von der CDU-Ministerin. Landwirte sollten Zugang zu fortschrittlichen Methoden bekommen. Beim “Global Forum for Food and Agriculture” (GFFA) im Januar in der Hauptstadt, stellten sich Vertreter des Bundeslandwirtschaftsministeriums offen hinter die neue Gentechnik, während Vertreter der Ernährungs- und Landwirtschaftsorganisation der Vereinten Nationen (FAO) auf “Agroökologie” und back-to-basics Landwirtschaft setzen. Die SPD ist unterdessen von Gen-Editing wenig überzeugt und meinte 2018, dass Klöckner das EUGH-Urteil einfach akzeptieren solle.

Zu Recht hat die Ministerin dies bisher nicht gemacht, denn das EUGH-Urteil ist an sich keine Abrechnung mit dieser Technik. Die 2001 GVO-Direktive ist veraltet, und beschreibt in ihrer Definition von genetischer Veränderung (Mutagenese) sogar Prozesse die in der Natur stattfinden, und nicht menschgemacht sind. Der EUGH in Luxemburg hat nach diesen Definitionen gehandelt, und nicht nach Vorsorgeprinzip. Existierende Gen-Editing Fortschritte sind wichtig für Medizin und Landwirtschaft, und benötigen politische Unterstützung.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Coronavirus Pandemic: Fred Roeder, Health Economist on TRT World


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Coronavirus: after the lockdown

Governments are beginning to discuss ways to reopen economies but massive investments and difficult choices lie ahead

As the UK and most of Europe enjoys glorious Easter sunshine, few people can take part in traditional festivities. With travel and social gatherings banned in most countries to reduce the transmission of coronavirus, many look forward desperately to emerging from a lockdown that is not only curtailing personal lives but also destroying businesses and the global economy.

Some European countries, including Austria, Denmark and Norway, have announced tentative plans to relax the most stringent measures later this month, for example by allowing some shops and schools to reopen. But governments in the nations hit hardest by Covid-19 — Italy, Spain, France and the UK — are reluctant to talk openly about exit strategies. They do not want to distract people from observing lockdowns while death tolls are still rising.

As Rishi Sunak, UK chancellor, declared this week: “The priority right now is to stop the spread of the virus and get us to the other side of the peak.” 

Behind closed doors, however, ministers and health officials everywhere are beginning to discuss what happens next. The debates about exit strategies focus on two themes: how to manage a staged and gradual reopening of some places of work, education, culture and entertainment; and what sort of “test and trace” regime would be needed to detect and suppress new virus outbreaks once the initial wave has subsided. 

Across Europe there are signs that observance of stringent social distancing measures by the vast majority of the public — better compliance than many experts had expected — has led to a big decline in viral transmission. The key figure is the “reproduction number” R measuring the average number of new cases generated by an infected individual. If R is above 1, an outbreak spreads; if it is below 1, it contracts. For Covid-19, R was between 2.5 and 3 in most places before any measures were introduced. 

According to a leading scientist in the UK’s fight against the disease, the latest evidence shows a steep fall in the R rate to around 0.6 now, which would quickly suppress the pandemic. However, deaths are still rising fast because of the delay between infection and when serious symptoms develop.  Patrick Vallance, UK chief scientist, said on Thursday there were clear signs of new cases levelling off. But he added: “I would expect the deaths to keep going up for two weeks.”  UK health secretary Matt Hancock.

Mr Sunak and his officials have had to innovate at speed to minimise hardship during the lockdown. But they also know that more companies will go bankrupt the longer the lockdown continues. As a result, ministers are thinking hard about how and when to lift restrictions, even if there is no perfect testing and tracing regime available. One minister says the focus was on three potential exit routes based on “populations, sectors and geography”. One option might be to let the young lead the way, perhaps starting by reopening schools, followed by a return to work for younger people who are less likely to become seriously ill if infected. Some are attracted to a Warwick university paper by Andrew Oswald and Nattavudh Powdthavee, suggesting removing restrictions on 20-30-year-olds who do not live with their parents, which could release 4.2m people. One official jokes that a “youth first” policy might mean “you could even have a maximum age for drinking in pubs”. 

Alok Sharma, business secretary, this week gave an indication of the kind of sectors that could be in the vanguard of an economic reawakening, when he offered more permissive guidance on social distancing rules. He told construction, manufacturing, logistics, essential retail, waste management and outdoor industries to apply the government’s advice to stay 2m apart but they were offered advice on how to stay open if that were not possible.  Ministers are less attracted to the idea of Britain reopening along geographical lines. Andy Burnham, mayor of Greater Manchester, says the lockdown can only work if it is “the same thing for the whole of the country.” Speaking to BBC Newsnight, he added: “It would be impossible to sustain here if there were images of people going back to pubs in other parts of the country.”

Although ministers representing the country’s economic interests stress that the priority is to save lives, they are starting to open up a debate about the wider damage caused by coronavirus.  The chancellor has been raising questions, reinforced this week by a report by the Institute for Fiscal Studies, about the longer-term health consequences of an extended lockdown and a deep recession, particularly on mental health and the wellbeing of poorer communities.  The subtext of this argument, raised at cabinet this week, is that it is possible to call for an easing of the lockdown without simply relying on cold economic arguments. “You have to look at the health picture in the round,” says one government official. 

The eventual easing of the lockdown in Britain and elsewhere will be accompanied by an intensive “test and trace” regime to detect and stamp out new outbreaks of the virus, once the initial surge has passed. Many governments are closely studying the experience in South Korea, which set up an extensive testing system to monitor new infections. If the UK can achieve its target of carrying out 100,000 tests a day by the end of April and ramp up capacity further over the following months, it will be possible to test individuals in the community who report Covid-19 symptoms.

In theory, this would then be followed by the tracing, testing and isolating of people who have been in contact with them if they are infected.  This type of contact tracing, which involves questioning patients directly, took place when the first UK cases were reported but soon stopped when the pandemic swamped the country’s extremely limited testing capacity.

“Evidence suggests that countries that are able to do very high levels of testing have many more options to allow people greater social mobility,” says Steven Riley, professor of infectious disease dynamics at Imperial College London. “Some really innovative solutions will play a part. Contact tracing based on a mobile phone app is being looked at.” 

However, apps designed to track and inform citizens when they meet people who have tested positive for coronavirus pose formidable practical and policy challenges for western democracies, from ensuring open operating standards to maintaining data security.  In China, for instance, these health apps are not mandatory in most places, but individuals can find themselves barred from work, public transport or even the public park if they cannot show their status on a virus-tracking app, which shows their movements in the previous fortnight. Privacy advocates aim to spot potential transgressions. “If tracking of individual movement is on the table, then that is unlikely to be in line with existing privacy laws, even in a crisis,” says Bill Wirtz, a Brussels-based analyst at the Consumer Choice Center. 

For many scientists, the key to ending the lockdowns is mass testing for Covid-19 infection, which detects the presence of the virus. Paul Romer, the Nobel Prize-winning economist, has outlined a plan for mass testing in the US that he believes would allow for much of the economy to reopen. However, this requires each person being tested every 14 days — or 22m tests a day — a mammoth undertaking in terms of labs, chemicals, health workers and data analysis, even if such tests are constitutionally acceptable.

In the UK, the epidemiologist Julian Peto has made a similar proposal — weekly tests, running to 10m a day. Large-scale antibody testing, to show whether individuals have been infected in the past and still have some immunity, is a more tantalising prospect because they would only need to be conducted occasionally and could potentially be bought at a pharmacy. But first they need to actually work. Specialised labs are carrying out studies to determine antibody levels in samples of the population but no one has yet developed an antibody kit reliable enough for widespread use in homes. Kits evaluated by the UK government have failure rates of 30 to 50 per cent.  Eventually antibody tests could give individuals “immunity passports” to show that they are safe from infection, Prof Riley says, “but there’s some very important science to do first”. The key questions that have still to be answered are how different antibody levels relate to resistance to infection and how long any immune protection is likely to last. 

Longer-term routes out of the coronavirus crisis require safe and effective treatments and vaccines. Dozens of existing drugs are in clinical trials to find out whether they help Covid-19 patients. Some may show efficacy but pharmacologists would be astonished if any turn out to be a magic bullet. Developing new drugs and vaccines will take more than a year, even with huge resources and regulatory goodwill.  Meanwhile governments still have a lack of knowledge about how the virus might return in a second wave and no real sense of how much immunity might build up in the population.  As Professor Neil Ferguson, the Imperial College epidemiologist and UK government adviser, told BBC Radio 4 on Friday, working out an exit strategy “is the number one topic and priority every waking minute, both in the scientific community and in government.” 

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

WHO Seeks $1 Billion Funding Boost from International Governments

The World Health Organisation (WHO) announced Thursday it is ready to launch an appeal for more than $US1 billion to underwrite operations against the Chinese coronavirus pandemic.

WHO Director-General Tedros Adhanom Ghebreyesus believes the pandemic needs a whole-of government and society response, and to that end is seeking a new funding lifeline outside its existing United Nations funding stream.

It follows a similar WHO call in February which sought $675 million in “special, one-off funding” to deliver two months worth of direct aid to China and international agencies.

Now it is back again and asking for more.

“For the past 100 days, our unwavering commitment has been to serve all people of the world with equity, objectivity and neutrality. That will continue to be our sole focus in the days, weeks and months ahead,” Dr Tedros said.

The appeal and strategy plan will commence in coming days, Reuters reports.Tedros Adhanom Ghebreyesus@DrTedros · Replying to @DrTedros

Our focus has been on working with countries & partners to bring the world together to confront this common threat together.
We’ve been especially concerned with protecting the world’s poorest & most vulnerable, not just in the poorest countries, but in all countries. #COVID19Tedros Adhanom Ghebreyesus@DrTedros

Although much has changed since we launched the first #COVID19 Strategic Preparedness & Response Plan two months ago, these five pillars will continue to be the foundation of our work in the fight against the #coronavirus.414Twitter Ads info and privacy159 people are talking about this

The WHO financial plea comes against a backdrop of controversy after U.S. President Donald Trump criticised the organisation over its handling of the COVID-19 pandemic and suggested his administration might re-evaluate U.S. funding.

Trump accused WHO of being “China-centric” and criticised its many missteps, nothing it responded to the virus very slowly and appeared deferential to China’s wishes in all its dealings, as Breitbart News reported.Donald J. Trump@realDonaldTrump

The W.H.O. really blew it. For some reason, funded largely by the United States, yet very China centric. We will be giving that a good look. Fortunately I rejected their advice on keeping our borders open to China early on. Why did they give us such a faulty recommendation?468KTwitter Ads info and privacy195K people are talking about this

The United States remains the biggest single overall donor to the globalist body, contributing more than $400 million in 2019 to the agency, roughly 15 percent of its budget.

In comparison, China’s contribution was about $44 million.

The WHO appeal for funding came within 24-hours of Consumer Choice Center, a global consumer advocacy group, launching its own campaign to defund it.

President Trump’s decision speaks to the larger inefficiencies and issues of transparency and accountability that have plagued the World Health Organization in recent years,” Yaël Ossowski, deputy director at the Consumer Choice Center, said in a statement he distributed to the press.

“While the failures of the WHO have only recently gotten publicity, this has been a long time coming,” Ossowski said.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

COVID-19: Retailers scrambling to respond to a surge in e-commerce orders during pandemic

Retailers have been left either struggling with a surge in demand for online ordering and delivery or ruing their lack of a web shop

Cannabis retailers in Ontario exhaled a collective sigh of relief earlier this week when the provincial government threw them a lifeline by finally — albeit temporarily — allowing them to offer online sales after shutting down their physical storefronts last weekend.

Previously, only the government-owned Ontario Cannabis Store was allowed to sell cannabis online, a “silly and misguided” policy, according to the Consumer Choice Centre, a consumer advocacy group. Now, for the time being, cannabis stores can offer delivery and curbside pickup.

Read more here


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Scroll to top
en_USEN